David G Belair

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Venues

Journal of biomedical materials research. Part A

Drug metabolism and disposition: the biological fate of chemicals

Scientific reports

PloS one

AbbVie

University of Wisconsin-Madison (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AbbVie Jan 21 2020

United States

Senior Scientist II - Toxicology :: Development Sciences

Celgene Corporation Nov 27 2017

United States

Scientist I/II - Investigative Toxicology :: Nonclinical Development

United States EPA - Nov 13 2017

United States

Postdoctoral Fellow :: ORD/NHEERL/TAD

Cellular Dynamics International, Inc.

United States

Intern :: Applications Development

Education History

University of Wisconsin-Madison

United States

PHD :: Biomedical Engineering

University of Wisconsin-Madison

United States

MSC :: Biomedical Engineering

Purdue University

United States

BSC :: Chemical Engineering

Publications

David A Kukla, David G Belair, David M Stresser
Evaluation and Optimization of a Microcavity Plate-Based Human Hepatocyte Spheroid Model for Predicting Clearance of Slowly Metabolized Drug Candidates. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Matthew B Parlato, Jae Sung Lee, David G Belair, Gianluca Fontana, Ellen Leiferman, Rewais Hanna, Connie Chamberlain, Erik A Ranheim, William L Murphy, Matthew A Halanski
Subperiosteal delivery of transforming growth factor beta 1 and human growth hormone from mineralized PCL films. Journal of biomedical materials research. Part A 112 (9) (2024)
Matthew B Parlato, Jae Sung Lee, David G Belair, Gianluca Fontana, Ellen Leiferman, Rewais Hanna, Connie Chamberlain, Erik A Ranheim, William L Murphy, Matthew A Halanski
Subperiosteal delivery of transforming growth factor beta 1 and human growth hormone from mineralized PCL films. Journal of biomedical materials research. Part A 112 (9) (2024)
Matthew B Parlato, Jae Sung Lee, David G Belair, Gianluca Fontana, Ellen Leiferman, Rewais Hanna, Connie Chamberlain, Erik A Ranheim, William L Murphy, Matthew A Halanski
Subperiosteal delivery of transforming growth factor beta 1 and human growth hormone from mineralized PCL films. Journal of biomedical materials research. Part A (2024)
David G Belair, Katelyn Sudak, Kimberly Connelly, Nathaniel D Collins, Stephan J Kopytek, Kyle L Kolaja
Investigation Into the Role of ERK in Tyrosine Kinase Inhibitor-Induced Neuropathy. Toxicological sciences : an official journal of the Society of Toxicology 181 (2) (2021)
David G Belair, Jae Sung Lee, Anna V Kellner, Johnny Huard, William L Murphy
Receptor mimicking TGF-β1 binding peptide for targeting TGF-β1 signaling. Biomaterials science 9 (3) (2021)
David G Belair, Gang Lu, Laura E Waller, Jason A Gustin, Nathaniel D Collins, Kyle L Kolaja
Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4. Scientific reports 10 (1) (2020)
David G Belair, Cynthia J Wolf, Carmen Wood, Hongzu Ren, Rachel Grindstaff, William Padgett, Adam Swank, Denise MacMillan, Anna Fisher, Witold Winnik, Barbara D Abbott
Engineering human cell spheroids to model embryonic tissue fusion in vitro. PloS one 12 (9) (2017)

David G Belair.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David G Belair